Validity and reliability of the health-related questionnaire IBDQ-32 in Mexican patients with inflammatory bowel disease

2021 ◽  
Vol 44 (10) ◽  
pp. 711-718
Author(s):  
Mónica R. Zavala-Solares ◽  
Lucero Salazar-Salas ◽  
Jesus K. Yamamoto-Furusho
2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Anne Beck ◽  
Palle Bager ◽  
Peter Errboe Jensen ◽  
Jens F. Dahlerup

Background. Fatigue is a significant aspect of everyday life for patients with inflammatory bowel disease (IBD), and it influences their health-related quality of life. Little is known about fatigue from the patient’s perspective.Aim. To investigate how female IBD patients experience and handle fatigue.Methods. The study included 11 female outpatients. These patients were 40–59 years old and had IBD ≥ one year and a significantly increased fatigue score. Patients with severe active IBD, anaemia, comorbidity, or pregnancy were excluded. The included patients agreed to participate in a semistructured interview. The interviews were analysed using Malterud’s principles of systematic text condensation.Results. The patients described physical and mental symptoms of fatigue that led to social-, physical-, and work-related limitations with emotional consequences. To handle fatigue, the patients used planning, priority, acceptance, exercise, and support. Two of the eleven patients used exercise on a regular basis. Surprisingly, some patients indicated that they did not need to talk with professionals about their fatigue unless a cure was available. Conclusion. Fatigue in IBD includes physical and mental symptoms that limit the patients’ social-, physical-, and work-related lives. Despite this, some patients expressed that they had chosen to accept their fatigue.


Molecules ◽  
2021 ◽  
Vol 26 (7) ◽  
pp. 1843
Author(s):  
Marilyn Hagan ◽  
Bu' Hussain Hayee ◽  
Ana Rodriguez-Mateos

(Poly)phenols (PPs) may have a therapeutic benefit in gastrointestinal (GI) disorders, such as irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD). The aim of this review is to summarise the evidence-base in this regard. Observational evidence does not give a clear indication that PP intake has a preventative role for IBD or IBS, while interventional studies suggest these compounds may confer symptomatic and health-related quality of life improvements in known patients. There are inconsistent results for effects on markers of inflammation, but there are promising reports of endoscopic improvement. Work on the effects of PPs on intestinal permeability and oxidative stress is limited and therefore conclusions cannot be formed. Future work on the use of PPs in IBD and IBS will strengthen the understanding of clinical and mechanistic effects.


2019 ◽  
Vol 17 (1) ◽  
pp. 107-118 ◽  
Author(s):  
Prisca Yue Min Ho ◽  
Wenjia Hu ◽  
Ying Yun Lee ◽  
Chuxi Gao ◽  
Yan Zhi Tan ◽  
...  

2008 ◽  
Vol 14 (7) ◽  
pp. 977-983 ◽  
Author(s):  
àngela Vidal ◽  
Esther Gómez-Gil ◽  
Miquel Sans ◽  
Maria J. Portella ◽  
Manel Salamero ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document